查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750649

登革热检测市场规模、份额、趋势分析报告：按产品类型、服务类型、最终用途、地区和细分市场预测，2025 年至 2030 年

Dengue Testing Market Size, Share & Trends Analysis Report By Product, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 195 Pages | 商品交期: 2-10个工作天内

价格

登革热检测市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球登革热检测市场规模预计到2030年将达到8.2261亿美元，2025-2030年期间的复合年增长率为5.22%。

都市化、气候变迁和国际旅行增加等因素正在扩大家猫的栖息地，而家猫是传播登革热的主要蚊媒。例如，2023年印度报告了近30万例登革热病例，凸显了亚太地区登革热疫情的日益严重。发病率的上升迫切需要开发和部署高效的诊断工具，以便早期发现和快速治疗，从而降低与疾病相关的发病率和死亡率。

诊断技术的创新显着提高了登革热检测的准确性和速度。酵素结合免疫吸附检测法(ELISA)、逆转录聚合酵素链锁反应(RT-PCR) 和快速抗原检测等先进方法的引入，彻底改变了这一领域。这些技术具有高灵敏度和特异性，使医疗保健提供者能够快速诊断登革热感染。此外，就地检验设备的开发促进了现场诊断，这在偏远和资源匮乏的地区至关重要。这些进步不仅改善了患者的预后，也有助于遏止感染的传播。

政府和国际合作在加强登革热检测市场方面发挥关键作用。 2024年8月，美国国际开发署(USAID) 向加勒比海公共卫生署 (CARPHA) 捐赠了价值2万美元的登革热和其他虫媒病毒检测套组，以加强该地区的疫情应对。此类倡议彰显了加强脆弱地区诊断能力的承诺。此外，美国食品药物管理局(FDA) 等监管机构正在加快审批创新诊断解决方案，例如生物梅里埃的 BIOFIRE FILMARRAY 热带发热检测组，该检测组于2024年12月获得了510(k) 特别许可。这些协同努力将扩大先进诊断工具的全球覆盖率和利用率。

随着人们对登革热及其影响的认识不断提高，诊断检测的需求也随之增加。公共卫生宣传活动和教育计画帮助社区了解了登革热的症状、传播和预防方法。这种认知鼓励人们及时就医，从而需要高效率的诊断服务。此外，知情的社区更有可能参与病媒控制活动，间接促进疾病控制。因此，重视教育和宣传在推动诊断市场发展方面发挥关键作用。

快速诊断检测 (RDT)套件的开发和普及彻底改变了登革热的检测方式，尤其是在流行地区。这些套件通常可在几分钟内快速提供结果，有助于临床快速做出决策。 2023 年 8 月，富士软片推出了其突破性的登革热 NS1 抗原检测套组，该试剂盒采用专有的银扩增技术，可实现早期诊断。此类技术创新对于降低疾病严重程度和死亡率至关重要。 RDT 的便利性、经济性和高效性使其成为全球对抗登革热的重要工具，从而推动了市场成长。

登革热检测市场报告重点

  • 根据产品，基于 ELISA 的检测领域将在 2024 年占据最大的市场占有率，达到 44.94%，这得益于高灵敏度、特异性以及检测登革热抗原 (NS1) 和抗体 (IgM 和 IgG) 的能力。
  • 根据服务类型，对准确和全面的检测解决方案的需求不断增长，使集中服务部门在 2024 年以 59.93% 的收入份额引领市场。集中实验室主要设立在医院和诊断中心，提供先进的诊断能力，例如 ELISA 和 RT-PCR 测试，这对于确认登革热感染至关重要。
  • 根据最终用途，临床检测领域占据市场主导地位，2024 年的收入份额为 44.16%。成长的动力来自于实验室自动化、高通量 ELISA 和 RT-PCR 平台的投资不断增加，这些平台可实现当天的周转时间。
  • 2024年，亚太地区以31.57%的市占率领先全球市场，主要得益于印度、印尼和泰国的登革热疫情。国家媒介控制计画（例如印度的NVBDCP）为当地实验室提供ELISA和RT-PCR检测资金，而当地卫生中心则部署了POC NS1快速检测。

目录

第一章调查方法与范围

第二章执行摘要

3. 登革热检测市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 登革热发生率上升
    • 技术进步
    • 政府和国际努力
  • 市场限制因素分析
    • 诊断测试成本高昂
    • 医疗基础设施使用受限
    • 波特五力分析
    • PESTEL分析

第四章 登革热检测市场：产品、估值与趋势分析

  • 登革热检测市场：产品差异分析
  • 按产品
  • 基于 ELISA 的检测
  • 登革热 IgG/IgM 检测套件
  • RT-PCR检测
  • 快速诊断测试（RDT）
  • NS1抗原检测套件
  • 侧流免疫检测

5. 登革热检测市场（按服务类型、估算和趋势分析）

  • 登革热检测市场：服务类型变化分析
  • 按服务类型
  • 集中服务
  • POC服务

6. 登革热检测市场：最终用途、预估及趋势分析

  • 登革热检测市场：最终用途变异分析
  • 按最终用途
  • 临床实验室
  • 医院/诊所
  • 家庭医疗保健

7. 登革热检测市场：区域、估计和趋势分析

  • 2024 年及 2030 年登革​​热检测市场占有率（按地区）
  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年北美登革热检测市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲登革热检测市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区登革热检测市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年拉丁美洲登革热检测市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东及非洲登革热检测市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 战略地图
  • 2024年公司市场占有率分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • InBios International, Inc.
    • NovaTec Immundiagnostica GmbH
    • Abnova Corporation
    • PerkinElmer Inc.（Euroimmun AG）
    • Certest BIoTec
    • DiaSorin SpA
    • Quest Diagnostics Incorporated
Product Code: GVR-4-68040-589-8

Dengue Testing Market Growth & Trends:

The global dengue testing market size is expected to reach USD 822.61 million by 2030, registering a CAGR of 5.22% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as urbanization, climate change, and increased international travel have expanded the habitats of Aedes mosquitoes, the primary vectors for dengue transmission. For instance, in 2023, India reported nearly 300,000 dengue cases, highlighting the disease's growing prevalence in Asia-Pacific region. This escalating incidence necessitates the development and deployment of efficient diagnostic tools to enable early detection and prompt treatment, thereby reducing morbidity and mortality associated with the disease.

Innovations in diagnostic technologies have significantly improved the accuracy and speed of dengue detection. The introduction of advanced methods such as enzyme-linked immunosorbent assays (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and rapid antigen tests has revolutionized the field. These technologies offer high sensitivity and specificity, enabling healthcare providers to diagnose dengue infections promptly. Moreover, the development of point-of-care testing devices facilitates on-site diagnostics, crucial in remote or resource-limited settings. Such advancements not only enhance patient outcomes but also contribute to controlling the spread of the disease.

Governmental and international efforts play a pivotal role in bolstering the dengue testing market. In August 2024, the United States Agency for International Development (USAID) donated dengue and other arbovirus test kits, valued at USD 20,000, to the Caribbean Public Health Agency (CARPHA) to enhance regional outbreak response. Such initiatives underscore the commitment to strengthening diagnostic capacities in vulnerable regions. Additionally, regulatory bodies like the U.S. Food and Drug Administration (FDA) have expedited the approval of innovative diagnostic solutions, such as bioMerieux's BIOFIRE FILMARRAY Tropical Fever Panel, which received Special 510(k) clearance in December 2024. These concerted efforts facilitate the availability and adoption of advanced diagnostic tools globally.

Heightened awareness about dengue fever and its implications has led to increased demand for diagnostic testing. Public health campaigns and educational programs have been instrumental in informing communities about the symptoms, transmission, and prevention of dengue. This awareness encourages individuals to seek timely medical attention, thereby necessitating efficient diagnostic services. Furthermore, informed communities are more likely to participate in vector control initiatives, indirectly contributing to disease management. The emphasis on education and awareness thus plays a critical role in driving the diagnostics market.

The development and availability of rapid diagnostic test (RDT) kits have transformed dengue detection, especially in endemic regions. These kits offer quick results, often within minutes, facilitating immediate clinical decisions. In August 2023, Fujifilm launched its revolutionary Dengue NS1Ag Test Kit, utilizing proprietary silver amplification technology to enable early diagnosis. Such innovations are crucial in mitigating disease severity and reducing mortality rates. The convenience, affordability, and efficiency of RDTs make them indispensable tools in the global fight against dengue, thereby propelling market growth.

Dengue Testing Market Report Highlights:

  • Based on product, the ELISA-based tests segment accounted for the largest market share of 44.94% in 2024, driven by their high sensitivity, specificity, and ability to detect both dengue antigens (NS1) and antibodies (IgM and IgG).
  • Based on service type, the centralized service segment led the market with a 59.93% revenue share in 2024, driven by the increasing demand for accurate and comprehensive testing solutions. Centralized laboratories, primarily located in hospitals and diagnostic centers, offer advanced diagnostic capabilities, including ELISA and RT-PCR tests, which are essential for confirming dengue infections
  • Based on end use, the clinical labs segment dominated the market with a revenue share of 44.16% in 2024. Growth is driven by increased investments in laboratory automation, high?throughput ELISA, and RT?PCR platforms, enabling same?day turnaround.
  • In 2024, Asia Pacific led the global market with a share of 31.57%, owing to endemic dengue transmission in India, Indonesia, and Thailand. National vector control programs (e.g., India's NVBDCP) fund ELISA and RT?PCR in regional labs, while community health centers deploy POC NS1 rapid tests.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Service Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Service Type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Dengue Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising Incidence of Dengue
    • 3.4.2. Technological Advancements
    • 3.4.3. Government and International Initiatives
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Diagnostic Tests
    • 3.5.2. Limited Access to Healthcare Infrastructure
    • 3.5.3. Porter's Five Forces Analysis
    • 3.5.4. PESTEL Analysis

Chapter 4. Dengue Testing Market: Product Estimates & Trend Analysis

  • 4.1. Dengue Testing Market: Product Movement Analysis
  • 4.2. Dengue Testing Market Estimates and Forecast, by Product
  • 4.3. ELISA-based Tests
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Dengue IgG/IgM Detection Kits
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. RT-PCR Tests
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Rapid Diagnostic Tests (RDTs)
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. NS1 Antigen Detection Kits
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Lateral Flow Immunoassay
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dengue Testing Market: Service Type Estimates & Trend Analysis

  • 5.1. Dengue Testing Market: Service Type Movement Analysis
  • 5.2. Dengue Testing Market Estimates and Forecast, by Service Type
  • 5.3. Centralized Service
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. POC Service
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dengue Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Dengue Testing Market: Distribution Movement Analysis
  • 6.2. Dengue Testing Market Estimates and Forecast, by End Use
  • 6.3. Clinical Labs
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Hospitals /Clinics
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dengue Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Dengue Testing Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Dengue Testing Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Abbott
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. F. Hoffmann-La Roche Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. InBios International, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. NovaTec Immundiagnostica GmbH
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Abnova Corporation
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. PerkinElmer Inc. (Euroimmun AG)
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Certest Biotec
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. DiaSorin S.p.A.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Quest Diagnostics Incorporated
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 3 Global Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 4 Global Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Dengue Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 9 North America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Europe America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 22 Europe America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 UK Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 UK Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 25 UK Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 France Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 France Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 31 France Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Italy Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Spain Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Norway Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Japan Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Japan Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 China Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 China Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 56 China Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 India Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 India Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 59 India Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Australia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Thailand Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 South Korea Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 South Korea Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 68 South Korea Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Dengue Testing Market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Dengue Testing Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Dengue testing market: Product movement analysis
  • Fig. 15 Dengue testing market: Product outlook and key takeaways
  • Fig. 16 ELISA-based Tests market estimates and forecast, 2018 - 2030
  • Fig. 17 Dengue IgG/IgM Detection Kits market estimates and forecast, 2018 - 2030
  • Fig. 18 RT-PCR Tests market estimates and forecast, 2018 - 2030
  • Fig. 19 Rapid Diagnostic Tests (RDTs) market estimates and forecast, 2018 - 2030
  • Fig. 20 NS1 Antigen Detection Kits market estimates and forecast, 2018 - 2030
  • Fig. 21 Lateral Flow Immunoassay market estimates and forecast, 2018 - 2030
  • Fig. 22 Dengue testing market: Service Type movement analysis
  • Fig. 23 Dengue testing market: Service Type outlook and key takeaways
  • Fig. 24 Centralized Service market estimates and forecast, 2018 - 2030
  • Fig. 25 POC Service market estimates and forecast, 2018 - 2030
  • Fig. 26 Dengue testing market: End use movement analysis
  • Fig. 27 Dengue testing market: End use outlook and key takeaways
  • Fig. 28 Clinical Labs market estimates and forecast, 2018 - 2030
  • Fig. 29 Hospitals /Clinics market estimates and forecast, 2018 - 2030
  • Fig. 30 Home Healthcare market estimates and forecast, 2018 - 2030
  • Fig. 31 Government Suppliers market estimates and forecast, 2018 - 2030
  • Fig. 32 Others market estimates and forecast, 2018 - 2030
  • Fig. 33 Regional outlook, 2024 & 2030
  • Fig. 34 Global Dengue Testing Market: Region movement analysis
  • Fig. 35 North America Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Dengue Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)